Quest Diagnostics Inc Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Quest Diagnostics Inc (DGX) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $27.00 million as of 2022-09-30, per its 10-Q filed 2022-10-21.
Discontinued › Notes › Intangible Assets
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2022-10-21
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $27.00M.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $53.00M.
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $80.00M.
- 2021-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $26.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2022-09-30 | $27.00M 10-Q · filed 2022-10-21 |
| 2022-06-30 | $53.00M 10-Q · filed 2022-07-22 |
| 2022-03-31 | $80.00M 10-Q · filed 2022-04-22 |
| 2021-09-30 | $26.00M 10-Q · filed 2021-10-22 |
| 2021-06-30 | $52.00M 10-Q · filed 2021-07-23 |
| 2021-03-31 | $74.00M 10-Q · filed 2021-04-23 |
| 2020-09-30 | $27.00M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $51.00M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $75.00M 10-Q · filed 2020-05-04 |
| 2019-09-30 | $24.00M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $49.00M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $74.00M 10-Q · filed 2019-04-24 |
| 2018-09-30 | $23.00M 10-Q · filed 2018-10-24 |
| 2018-06-30 | $44.00M 10-Q · filed 2018-07-25 |
| 2018-03-31 | $66.00M 10-Q · filed 2018-04-20 |
| 2017-09-30 | $19.00M 10-Q · filed 2017-10-19 |
| 2017-06-30 | $36.00M 10-Q · filed 2017-07-25 |
| 2017-03-31 | $52.00M 10-Q · filed 2017-04-21 |
| 2016-09-30 | $18.00M 10-Q · filed 2016-10-21 |
| 2016-06-30 | $36.00M 10-Q · filed 2016-07-25 |
| 2016-03-31 | $54.00M 10-Q · filed 2016-04-27 |
| 2015-09-30 | $19.00M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $39.00M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $59.00M 10-Q · filed 2015-04-30 |
| 2014-09-30 | $24.00M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $47.00M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $67.00M 10-Q · filed 2014-05-01 |
| 2013-09-30 | $19.93M 10-Q · filed 2013-10-24 |
| 2013-06-30 | $40.54M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $57.79M 10-Q · filed 2013-04-24 |
| 2012-09-30 | $19.95M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $39.82M 10-Q · filed 2012-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |